Although the intrinsic signaling pathways targeted by phytochemicals in cancer treatment of cancer is still unknown, previous studies have shown that they can suppress both the STAT NF‐B, PIK/AKT, and MAPK signaling pathways and activate some genes that are responsible for tumor suppressor activity in a variety of cancer models.18 This evidence concerns the gene AKT1 and cancer.